Kenneth Kovan

Kenneth Kovan

Fortuna: 77 629 $ al 30/09/2026

Health Technology
Consumer Services
Commercial Services

Perfil

Kenneth E.
Kovan
is the founder of AVAX Technologies, Inc., founded in 1990.
Mr. Kovan is the founder of Bingham Hill Ventures, founded in 2012, holding the title of Managing Principal.
Mr. Kovan is also the founder of BioVaxys Technology Corp.,BioVaxys LLC.
Mr. Kovan is currently the President of Chaperone Technologies, Inc. Former positions include Principal at Thomas Jefferson University, Principal at GSK Plc, Principal at Wyeth-Ayerst Research, and Partner at Revvity Discovery Ltd.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
20/10/2025 935.286 ( 2,12 % ) 77 629 $ 30/09/2026

Cargos activos de Kenneth Kovan

EmpresasCargoInicio
BIOVAXYS TECHNOLOGY CORP. Fundador 25/04/2018
Presidente -
Fundador -
Bingham Hill Ventures
Fundador 01/01/2012

Antiguos cargos conocidos de Kenneth Kovan.

EmpresasCargoFin
Corporate Officer/Principal -
Wyeth-Ayerst Research
Corporate Officer/Principal -
GSK PLC Corporate Officer/Principal -
Corporate Officer/Principal -
AVAX TECHNOLOGIES, INC. Fundador -
Ver el detalle de la experiencia de Kenneth Kovan.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

18

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas9

Health Technology

Consumer Services

Health Technology

Wyeth-Ayerst Research

Health Technology

Commercial Services

Non-Energy Minerals

Health Technology

Bingham Hill Ventures